
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cerebrovasc Dis Extra</journal-id><journal-id journal-id-type="iso-abbrev">Cerebrovasc Dis Extra</journal-id><journal-id journal-id-type="publisher-id">CEE</journal-id><journal-title-group><journal-title>Cerebrovascular Diseases Extra</journal-title></journal-title-group><issn pub-type="ppub">1664-5456</issn><issn pub-type="epub">1664-5456</issn><publisher><publisher-name>S. Karger AG</publisher-name><publisher-loc>Allschwilerstrasse 10, P.O. Box &#x000b7; Postfach &#x000b7; Case postale, CH&#x02013;4009, Basel, Switzerland &#x000b7; Schweiz &#x000b7; Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24403903</article-id><article-id pub-id-type="pmc">3884179</article-id><article-id pub-id-type="doi">10.1159/000354847</article-id><article-id pub-id-type="publisher-id">cee-0003-0121</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>A Daily Glass of Red Wine and Lifestyle Changes Do Not Affect Arterial Blood Pressure and Heart Rate in Patients with Carotid Arteriosclerosis after 4 and 20 Weeks</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Droste</surname><given-names>Dirk W.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Iliescu</surname><given-names>Catalina</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vaillant</surname><given-names>Michel</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gantenbein</surname><given-names>Manon</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>De Bremaeker</surname><given-names>Nancy</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lieunard</surname><given-names>Charlotte</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Velez</surname><given-names>Telma</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Meyer</surname><given-names>Mich&#x000e8;le</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Guth</surname><given-names>Tessy</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kuemmerle</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chioti</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib></contrib-group><aff id="aff1"><sup>a</sup>Department of Neurology, Centre Hospitalier de Luxembourg, Luxembourg, Luxemburg</aff><aff id="aff2"><sup>b</sup>Clinical and Epidemiological Investigation Centre, Luxemburg</aff><aff id="aff3"><sup>c</sup>Methodology and Statistical Competence Centre, Luxemburg</aff><aff id="aff4"><sup>d</sup>Centre of Health Studies, Centre de Recherche Public-Sant&#x000e9;, Strassen, Luxemburg</aff><author-notes><corresp id="cor1">*Prof. Dr. Dirk W. Droste, Service de Neurologie, Centre Hospitalier de Luxembourg, 4 rue Barbl&#x000e9;, LU-1210 Luxembourg (Luxemburg), E-Mail <email>droste.dirk@chl.lu</email></corresp></author-notes><pub-date pub-type="collection"><season>Jan-Dec</season><year>2013</year></pub-date><pub-date pub-type="epub"><day>5</day><month>10</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>5</day><month>10</month><year>2013</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>3</volume><issue>1</issue><fpage>121</fpage><lpage>129</lpage><permissions><copyright-statement>Copyright &#x000a9; 2013 by S. Karger AG, Basel</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.</license-p></license></permissions><abstract><sec><title>Background</title><p>Regular consumption of small amounts of red wine improves blood lipids. However, there is concern whether this beneficial effect might be counterbalanced by an increase in blood pressure (BP) and heart rate (HR), which are risk factors for cerebro-cardiovascular disease. In particular, we studied whether regular consumption of red wine with and without lifestyle changes (LC; healthy diet and physical activity advice) results in an increase in BP and HR.</p></sec><sec><title>Methods</title><p>A prospective, unblinded randomized trial was performed in 108 patients (67% men) with carotid atherosclerosis documented by ultrasound, a mean BP of 122/79 mm Hg and a mean HR of 71 bpm at inclusion in the study. Sixty-eight percent were known and treated hypertensives. The mean 24-hour BP at baseline was 122/79 mm Hg. Half of the study participants, the control group, was seen by a nurse at baseline, after 4 and after 20 weeks, and was instructed not to change their eating and physical activity habits. In the other half, a dietician performed five sessions of 30 min each (at baseline, after 1 week and after 2, 3 and 4 weeks) giving advice on healthy eating based on a Mediterranean diet and physical exercise. The recommendations given were the following: 5 portions of fruit/vegetables per day, a diet low in absolute fat, a preference of vegetable oil (olive or rapeseed oil), whole-grain products, poultry, low-fat dairy products, 1 fat and 1 lean fish meal per week, reduced consumption of red meat, and avoidance of pork, ready-made meals, sugar and excessive salt intake. In addition, regular consumption of 1 bar of dark chocolate (25 g, &#x0003e;70% of cacao), 1-2 tomatoes, and 3-5 walnuts as well as at least 30 min of moderate daily physical activity were recommended. Within these two groups, half of the patients were randomized either to avoid alcohol completely or to drink 100 ml (women) or 200 ml of red wine (men) daily.</p></sec><sec><title>Results</title><p>Neither LC nor red wine had an effect on the mean systolic and diastolic 24-hour BP and HR after 4 and 20 weeks, as analyzed by general linear modeling. No difference was found for diurnal and nocturnal values.</p></sec><sec><title>Conclusions</title><p>The possible beneficial effect of regular consumption of small amounts of red wine is not counterbalanced in the long term by an increase in the mean BP or HR in mainly normotensive and well-treated hypertensive patients with carotid atherosclerosis, neither in the patients given healthy lifestyle advice nor in those with a standard lifestyle. Yet, we remain cautious about actively advice patients to drink alcohol regularly given the well-known risks.</p></sec></abstract><kwd-group><title>Key Words&#x02029;</title><kwd>Alcohol</kwd><kwd>Carotid arteries</kwd><kwd>Diet</kwd><kwd>Blood pressure</kwd><kwd>Nutrition&#x02029;</kwd></kwd-group><counts><table-count count="3"/><ref-count count="40"/><page-count count="9"/></counts></article-meta></front><body><sec id="sec1_1"><title>Introduction</title><p>Lifestyle changes (LC) including physical exercise and a Mediterranean diet improve the lipid profile. Physical exercise mainly increases HDL and reduces triglycerides; LDL is hardly affected [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. In their recent meta-analysis, Kastorini et al. [<xref ref-type="bibr" rid="B3">3</xref>] found an increase in HDL and a decrease in triglycerides when comparing a Mediterranean diet with a conventional diet. Some of the studies included red wine and others did not. Three food items in particular have been shown to improve the lipid profile: dark chocolate, tomatoes and walnuts, the latter two being frequently part of a Mediterranean diet [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. Mediterranean diets [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>] as well as physical activity are known to lower blood pressure (BP) [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Alcohol consumption and especially binge drinking are risk factors for high BP and cerebro-cardiovascular disease [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. Light to moderate alcohol consumption, and possibly in particular red wine consumption, is associated with a smaller risk for cerebro- and cardiovascular disease and an improved lipid profile [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. Little is known on the effect of regular consumption of small quantities of alcohol on BP and heart rate (HR).</p><p>In this prospective, unblinded, randomized controlled trial, we assessed the effect of a small amount of red wine and LC, including the consumption of dark chocolate, tomatoes and walnuts associated with physical activity, on BP and HR in patients with arteriosclerosis documented by carotid ultrasound. In particular, we studied whether consumption of red wine on top of LC results in an increase in BP, thus counterbalancing the beneficial effect on blood lipids. The present work is part of the ALVINA project (an acronym of &#x02018;alimentation, vin, et activit&#x000e9; physique&#x02019; meaning &#x02018;nutrition, wine, and physical activity&#x02019; in French), in which also other parameters were studied. The study outline, patients' baseline characteristics, results on lipids and the efficacy of lifestyle counseling are reported or submitted for publication elsewhere [<xref ref-type="bibr" rid="B22">22</xref>].</p></sec><sec sec-type="methods" id="sec1_2"><title>Methods</title><p>The study complies with the Declaration of Helsinki and was performed in Luxemburg after protocol approval by the National Research Ethics Committee (200801/06) and notification to the National Commission for Data Protection. The trial was registered at <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov">http://www.clinicaltrials.gov</ext-link> (NCT01146132). The first patient was included on June 4, 2009, and the last follow-up visit took place on October 10, 2011.</p><p>Hundred and twenty-two patients were followed up to 20 weeks. The enrolled participants were outpatients of the Department of Neurology and had undergone carotid and intracranial bitemporal color-coded duplex sonography carried out with the Antares system (Siemens Healthcare, Erlangen, Germany). Inclusion criteria were age &#x0003e;30 years and the presence of plaques or stenosis without hemodynamic compromise (i.e. &#x0003c;70%) in at least one common carotid artery, the carotid bifurcation or the internal carotid artery. Exclusion criteria were a history of ocular or cerebral ischemia within the last 3 months, atrial fibrillation, a repeatedly measured systolic BP (SBP) &#x0003e;160 mm Hg or the incapacity to give informed consent. The experimental design of the study was a 2 &#x000d7; 2 factorial design. The patients were allocated to groups of different lifestyles in result of a randomization stratified for gender. Lots were drawn to generate the random allocation sequence, and block size was 4. The intervention allocation was concealed in a nontransparent envelope. The random allocation sequence was generated by an independent staff member; patients were enrolled by the principal investigator and were assigned to interventions by the study nurse. A first group received no lifestyle counseling and the second one received lifestyle counseling at baseline and after 1, 2, 3 and 4 weeks. Within each lifestyle group, the patients were either randomly advised to drink a glass of red wine a day (0.2 liter for males and 0.1 liter for females) or they were advised to avoid alcohol completely for the time of the study.</p><p>In the LC group, a dietician performed five sessions of 30 min each (at baseline, after 1 week and after 2, 3 and 4 weeks) giving advice on healthy eating based on a Mediterranean diet and physical exercise. In particular, 5 portions of fruit/vegetables per day, a diet low in absolute fat, a preference of vegetable oil (olive or rapeseed oil), whole-grain products, poultry, low-fat dairy products, 1 fat and 1 lean fish meal per week, reduced consumption of red meat and avoidance of pork, ready-made meals, sugar and excessive salt intake were recommended [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. A water intake of 1.5-2 liters a day was recommended as well. In addition, regular consumption of 1 bar of dark chocolate (25 g, &#x0003e;70% of cacao), 1-2 tomatoes, 3-5 walnuts as well as at least 30 min of moderate daily physical activity was recommended [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. The control group (no LC) was seen at baseline, after 4 and after 20 weeks by a nurse who instructed the patients not to change their eating and physical activity habits. The patients allocated to the wine group (within the LC and the no LC groups) underwent three short sessions of counseling by the nurse concerning the intake of red wine of their choice (200 ml for males and 100 ml for females) [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>].</p><p>For the 24-hour BP and HR monitoring, we used the Cardioline Walk200b system (CARDIOLINE S.p.A., Cavareno, Italy). Measurements were carried out every 20 min during daytime (7:00 a.m.-09:59 p.m.) and every 30 min during nighttime using the same upper arm in each individual for follow-up measurements.</p><p>The predefined primary endpoint of the study was a change in the mean 24-hour SBP assessed at baseline and at 20 weeks. Secondary endpoints were changes in the mean 24-hour DBP, the mean 24-hour HR, the mean diurnal and nocturnal SBP, the mean diurnal and nocturnal DBP and the mean diurnal and nocturnal HR assessed at baseline and at 20 weeks as well as at baseline and at 4 weeks. As there are gender differences in alcohol distribution and metabolism, general linear model analyses were also stratified by gender.</p><p>The intent-to-treat (ITT) and per-protocol (PP) populations were defined in order to show the effect of the intervention given the environment of the patients for the former, and to show the true effect of the intervention of all other parameters being controlled. The ITT population included only patients who had attended the first and at least the 4-week visit. The PP included the ITT patients and excluded those who admitted not to have followed the instructions or who did not present themselves at the 20-week visit. The ITT population was the primary population. The groups (defined by LC and red wine intake) were compared at their baseline values. For continuous variables, normality was verified using the Shapiro-Wilk test. Where the values were normally distributed, a two-sample t test was used. Otherwise, the Wilcoxon-Mann-Whitney test was applied. Dichotomous data was compared using Pearson's &#x003c7;<sup>2</sup> test. In case the expected cell frequencies were lower than 5, Fisher's exact test was applied. A general linear model with Tukey-Kramer adjustment for multiple comparisons was used to assess the primary endpoints. The absolute change value represented the dependent value. In case the normality assumption of the model residuals was violated, ANOVA on ranks was used. A p value below 0.05 was considered significant. All tests were two-tailed, and all analyses were performed by using the SAS System v9.2 (SAS Institute, Cary, N.C., USA).</p></sec><sec sec-type="results" id="sec1_3"><title>Results</title><p>The ITT population included 108 subjects. Out of the 122 selected patients, 14 were closed out because they dropped out of the study before the 4- or 20-week visit. The PP population excluded 3 patients of the wine group who never drank wine during the study, 3 patients who drank considerable amounts of alcohol in the abstinent group, and 2 patients who did not attend the 20-week visit but had attended the 4-week visit. Therefore, the PP population included 100 patients.</p><p>The groups were well balanced (table <xref ref-type="table" rid="T1">1</xref>). The mean daily alcohol intake at baseline was 14.6 g with a maximum of 57 g. No difference was found between the groups. There was homogeneity between the groups in all baseline parameters. No serious adverse events related to the study were recorded. Table <xref ref-type="table" rid="T2">2</xref> gives the distribution of the baseline BP values in relation to the classification of the European Society of Hypertension [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. Most subjects were normotensives (or treated hypertensives).</p><p>Table <xref ref-type="table" rid="T3">3</xref> gives the results for the primary endpoint and the secondary endpoints in the ITT population. There was no effect of the interventions on the 24-hour, diurnal and nocturnal SBP, DBP and the mean HR difference between the baseline and 4- and 20-week values, as analyzed by general linear modeling. In the PP analysis, however, despite the fact that the global explanation was not significant with p = 0.2142, there was a significant effect of wine on the nocturnal HR (p = 0.0178, rank model) after 4 weeks. This effect was only significant in the LC group, indicating a higher nocturnal HR in the wine drinkers compared to the no wine drinkers with a mean difference of 4.2 bpm.</p></sec><sec sec-type="discussion" id="sec1_4"><title>Discussion</title><p>Our study failed to find evidence of an effect of regular, small amounts of red wine on the mean 24-hour BP and HR in patients with carotid arteriosclerosis, neither after 4 weeks nor after 20 weeks. Therefore, the beneficial effect a daily glass of red wine on blood lipids is not counterbalanced by a raise in BP or HR [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. We did not find any effect of LC including Mediterranean diet and physical exercise on BP and HR. Only the PP analysis in the LC group showed a higher nocturnal HR (mean difference 4.2 bpm) in the wine drinkers compared to the no wine drinkers.</p><p>Mediterranean diets are known to lower BP [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. The effect is pronounced if weight loss is associated with the diet [<xref ref-type="bibr" rid="B31">31</xref>]; however, without weight loss, the situation is less clear and 2 large studies reported that there is only a beneficial effect on blood lipids but not on BP [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. This is in line with our study, where no effects on weight and BP were found. Moreover, the DASH trial had already found that the effect of diet on BP is more pronounced in hypertensive patients [<xref ref-type="bibr" rid="B33">33</xref>]. The participants in our study were mainly normotensive (either primarily or treated).</p><p>Physical activity has also been described to lower BP [<xref ref-type="bibr" rid="B10">10</xref>,][<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. However, this effect seems to be restricted to younger patients. After 6 months, there was no effect of exercise on SBP and only a mild effect on DBP (&#x02212;2.2 mm Hg) in 55- to 75-year-old patients with mild hypertension compared to a control group [<xref ref-type="bibr" rid="B34">34</xref>]. A reason could be aortic stiffness in this age group, similar to the age group in our study.</p><p>Alcohol has a biphasic effect on BP and HR. An initial vasodilatation with a drop in BP is followed by vasoconstriction and a rise in BP [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. The drop in BP is accompanied by a rise in HR and vice versa [<xref ref-type="bibr" rid="B35">35</xref>]. On the first day of alcohol intake, the mean 24-hour BP dropped and HR increased compared to baseline. However, after 7 days of regular alcohol intake at dinner, no changes in the mean 24-hour BP and HR were noted in 14 male habitual drinkers with essential hypertension in the study by Abe et al. [<xref ref-type="bibr" rid="B35">35</xref>]. However, after 7 days, BP was lower and HR higher between 6 p.m. and midnight. Between midnight and 8 a.m., BP was higher as compared to baseline [<xref ref-type="bibr" rid="B35">35</xref>]. We did not find any effect of regular alcohol intake on the 24-hour BP and HR values. Reasons for this finding were that (a) the time of alcohol intake was at the subject's discretion; (b) BP and HR were measured after 4 and 20 weeks, respectively, and (c) there was an attenuation of the BP and HR reaction to alcohol with time, which has already been described in the study by Abe [<xref ref-type="bibr" rid="B35">35</xref>].</p><p>Heavy alcohol consumption and binge drinking are risk factors for high BP and cerebro-cardiovascular disease [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. Cessation of heavy alcohol intake (100-380 g daily) in men reduced SBP and DBP by 7 mm Hg and HR by 8 bpm after 1 month [<xref ref-type="bibr" rid="B38">38</xref>]. In our study, the mean daily alcohol intake at baseline was 14.6 g with a maximum of 57 g daily, and the amount studied was about 12 and 24 g, respectively. These values were far lower and the effects of withdrawal and exposition were less pronounced, which explains our different results. During our study, a continuous, small amount of daily alcohol intake was administered, and binge drinking was discouraged in both the wine drinkers and the no wine drinkers.</p><p>Zilkens et al. [<xref ref-type="bibr" rid="B39">39</xref>] compared 4 weeks of control abstinence with similar periods of daily consumption of red wine (375 ml), dealcoholized red wine (375 ml) or beer (1,125 ml) in 28 normotensive menin random order. The ambulatory SBP, DBP and HR were not different between control abstinence and dealcoholized red wine. However, compared with control abstinence, both red wine and beer increased awake SBP (2.9 and 1.9 mm Hg, respectively; p &#x0003c; 0.05) and asleep HR (5.0 and 4.4 bpm; p &#x0003c; 0.05). The amount of alcohol used in this study (375 ml of wine and 1,125 ml of beer, respectively) was higher than the one we used (100 and 200 ml of red wine, respectively). This may explain why HR and BP did not change in the long term in our study. In the PP population of our study, there was only a transient increase in the nocturnal HR of the LC group that was drinking wine for 4 weeks as compared with the LC group that did not drink wine at all.</p><p>Alcohol shows interactions with BP medication. Drinkers show lower levels of telmisartan as compared to non-drinkers when taking the same dose of telmisartan [<xref ref-type="bibr" rid="B40">40</xref>]. A majority of the subjects in our study was on angiotensin II receptor antagonists. Nevertheless, there was no increase in BP in the wine-drinking group.</p><p>Our study demonstrates that in mainly normotensive and well-treated hypertensive patients with cerebrovascular disease, the possible effect of the regular intake of small amounts of red wine is not counterbalanced by an increase in the mean SBP or DBP or by an increase in HR in the long term. Limitations of our study are the relatively small number of participants subdivided into four groups and the fact that we studied the effect of counseling and not the actual change in behavior.</p></sec><sec id="sec1_5"><title>Disclosure Statement</title><p>None of the authors had a personal or financial conflict of interest.</p></sec></body><back><ack><title>Acknowledgments</title><p>We are very grateful to Mrs. S. Spinelli (dietician) and to Prof. S. Senn (statistics) for their helpful comments.</p><p>The Centre de Recherche Public-Sant&#x000e9; sponsored this study (rooms, personnel, technical devices and investigations). The Centre Hospitalier de Luxembourg authorized Prof. Droste to spend part of his working time on this study and provided rooms, logistical and secretarial support.</p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trejo-Gutierrez</surname><given-names>JF</given-names></name><name><surname>Fletcher</surname><given-names>G</given-names></name></person-group><article-title>Impact of exercise on blood lipids and lipoproteins</article-title><source>J Clin Lipidol</source><year>2007</year><volume>1</volume><fpage>175</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">21291678</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>WV</given-names></name><name><surname>Fletcher</surname><given-names>GF</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name></person-group><article-title>Using exercise to reduce risk</article-title><source>J Clin Lipidol</source><year>2009</year><volume>3</volume><fpage>360</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">21291837</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kastorini</surname><given-names>CM</given-names></name><name><surname>Milionis</surname><given-names>HJ</given-names></name><name><surname>Esposito</surname><given-names>K</given-names></name><name><surname>Giugliano</surname><given-names>D</given-names></name><name><surname>Goudevenos</surname><given-names>JA</given-names></name><name><surname>Panagiotakos</surname><given-names>DB</given-names></name></person-group><article-title>The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals</article-title><source>J Am Coll Cardiol</source><year>2011</year><volume>57</volume><fpage>1299</fpage><lpage>1313</lpage><pub-id pub-id-type="pmid">21392646</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buitrago-Lopez</surname><given-names>A</given-names></name><name><surname>Sanderson</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>L</given-names></name><name><surname>Warnakula</surname><given-names>S</given-names></name><name><surname>Wood</surname><given-names>A</given-names></name><name><surname>Di</surname><given-names>AE</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name></person-group><article-title>Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis</article-title><source>BMJ</source><year>2011</year><volume>343</volume><fpage>d4488</fpage><pub-id pub-id-type="pmid">21875885</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokede</surname><given-names>OA</given-names></name><name><surname>Gaziano</surname><given-names>JM</given-names></name><name><surname>Djousse</surname><given-names>L</given-names></name></person-group><article-title>Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis</article-title><source>Eur J Clin Nutr</source><year>2011</year><volume>65</volume><fpage>879</fpage><lpage>886</lpage><pub-id pub-id-type="pmid">21559039</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname><given-names>A</given-names></name><name><surname>Merei</surname><given-names>M</given-names></name><name><surname>Karem</surname><given-names>A</given-names></name><name><surname>Blum</surname><given-names>N</given-names></name><name><surname>Ben Arzi</surname><given-names>S</given-names></name><name><surname>Wirsansky</surname><given-names>I</given-names></name><name><surname>Khazim</surname><given-names>K</given-names></name></person-group><article-title>Effects of tomatoes on the lipid profile</article-title><source>Clin Invest Med</source><year>2006</year><volume>29</volume><fpage>298</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">17144439</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silaste</surname><given-names>ML</given-names></name><name><surname>Alfthan</surname><given-names>G</given-names></name><name><surname>Aro</surname><given-names>A</given-names></name><name><surname>Kesaniemi</surname><given-names>YA</given-names></name><name><surname>Horkko</surname><given-names>S</given-names></name></person-group><article-title>Tomato juice decreases LDL cholesterol levels and increases LDL resistance to oxidation</article-title><source>Br J Nutr</source><year>2007</year><volume>98</volume><fpage>1251</fpage><lpage>1258</lpage><pub-id pub-id-type="pmid">17617941</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabate</surname><given-names>J</given-names></name><name><surname>Oda</surname><given-names>K</given-names></name><name><surname>Ros</surname><given-names>E</given-names></name></person-group><article-title>Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials</article-title><source>Arch Intern Med</source><year>2010</year><volume>170</volume><fpage>821</fpage><lpage>827</lpage><pub-id pub-id-type="pmid">20458092</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banel</surname><given-names>DK</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name></person-group><article-title>Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review</article-title><source>Am J Clin Nutr</source><year>2009</year><volume>90</volume><fpage>56</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">19458020</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frisoli</surname><given-names>TM</given-names></name><name><surname>Schmieder</surname><given-names>RE</given-names></name><name><surname>Grodzicki</surname><given-names>T</given-names></name><name><surname>Messerli</surname><given-names>FH</given-names></name></person-group><article-title>Beyond salt: lifestyle modifications and blood pressure</article-title><source>Eur Heart J</source><year>2011</year><volume>32</volume><fpage>3081</fpage><lpage>3087</lpage><pub-id pub-id-type="pmid">21990264</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>C</given-names></name><name><surname>Couture</surname><given-names>P</given-names></name><name><surname>Desroches</surname><given-names>S</given-names></name><name><surname>Charest</surname><given-names>A</given-names></name><name><surname>Lamarche</surname><given-names>B</given-names></name></person-group><article-title>Effect of the Mediterranean diet with and without weight loss on cardiovascular risk factors in men with the metabolic syndrome</article-title><source>Nutr Metab Cardiovasc Dis</source><year>2011</year><volume>21</volume><fpage>628</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">20554173</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickinson</surname><given-names>HO</given-names></name><name><surname>Mason</surname><given-names>JM</given-names></name><name><surname>Nicolson</surname><given-names>DJ</given-names></name><name><surname>Campbell</surname><given-names>F</given-names></name><name><surname>Beyer</surname><given-names>FR</given-names></name><name><surname>Cook</surname><given-names>JV</given-names></name><name><surname>Williams</surname><given-names>B</given-names></name><name><surname>Ford</surname><given-names>GA</given-names></name></person-group><article-title>Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials</article-title><source>J Hypertens</source><year>2006</year><volume>24</volume><fpage>215</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">16508562</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>A</given-names></name><name><surname>Di Raimondo</surname><given-names>D</given-names></name><name><surname>Tuttolomondo</surname><given-names>A</given-names></name><name><surname>Fernandez</surname><given-names>P</given-names></name><name><surname>Arnao</surname><given-names>V</given-names></name><name><surname>Licata</surname><given-names>G</given-names></name></person-group><article-title>Twenty-four hour ambulatory blood pressure monitoring to evaluate effects on blood pressure of physical activity in hypertensive patients</article-title><source>Clin J Sport Med</source><year>2006</year><volume>16</volume><fpage>238</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">16778545</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whelton</surname><given-names>SP</given-names></name><name><surname>Chin</surname><given-names>A</given-names></name><name><surname>Xin</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>J</given-names></name></person-group><article-title>Review: aerobic exercise reduces systolic and diastolic blood pressure in adults</article-title><source>Ann Intern Med</source><year>2002</year><volume>136</volume><fpage>493</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">11926784</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillbom</surname><given-names>M</given-names></name><name><surname>Saloheimo</surname><given-names>P</given-names></name><name><surname>Juvela</surname><given-names>S</given-names></name></person-group><article-title>Alcohol consumption, blood pressure, and the risk of stroke</article-title><source>Curr Hypertens Rep</source><year>2011</year><volume>13</volume><fpage>208</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">21327566</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloner</surname><given-names>RA</given-names></name><name><surname>Rezkalla</surname><given-names>SH</given-names></name></person-group><article-title>To drink or not to drink?</article-title><source>That is the question. Circulation</source><year>2007</year><volume>116</volume><fpage>1306</fpage><lpage>1317</lpage></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avellone</surname><given-names>G</given-names></name><name><surname>Di Garbo</surname><given-names>V</given-names></name><name><surname>Campisi</surname><given-names>D</given-names></name><name><surname>De Simone</surname><given-names>R</given-names></name><name><surname>Raneli</surname><given-names>G</given-names></name><name><surname>Scaglione</surname><given-names>R</given-names></name><name><surname>Licata</surname><given-names>G</given-names></name></person-group><article-title>Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis</article-title><source>Eur J Clin Nutr</source><year>2006</year><volume>60</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">16132058</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coimbra</surname><given-names>SR</given-names></name><name><surname>Lage</surname><given-names>SH</given-names></name><name><surname>Brandizzi</surname><given-names>L</given-names></name><name><surname>Yoshida</surname><given-names>V</given-names></name><name><surname>da Luz</surname><given-names>PL</given-names></name></person-group><article-title>The action of red wine and purple grape juice on vascular reactivity is independent of plasma lipids in hypercholesterolemic patients</article-title><source>Braz J Med Biol Res</source><year>2005</year><volume>38</volume><fpage>1339</fpage><lpage>1347</lpage><pub-id pub-id-type="pmid">16138217</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krenz</surname><given-names>M</given-names></name><name><surname>Korthuis</surname><given-names>RJ</given-names></name></person-group><article-title>Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms</article-title><source>J Mol Cell Cardiol</source><year>2012</year><volume>52</volume><fpage>93</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">22041278</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Keefe</surname><given-names>JH</given-names></name><name><surname>Bybee</surname><given-names>KA</given-names></name><name><surname>Lavie</surname><given-names>CJ</given-names></name></person-group><article-title>Alcohol and cardiovascular health: the razor-sharp double-edged sword</article-title><source>J Am Coll Cardiol</source><year>2007</year><volume>50</volume><fpage>1009</fpage><lpage>1014</lpage><pub-id pub-id-type="pmid">17825708</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smoliga</surname><given-names>JM</given-names></name><name><surname>Baur</surname><given-names>JA</given-names></name><name><surname>Hausenblas</surname><given-names>HA</given-names></name></person-group><article-title>Resveratrol and health-a comprehensive review of human clinical trials</article-title><source>Mol Nutr Food Res</source><year>2011</year><volume>55</volume><fpage>1129</fpage><lpage>1141</lpage><pub-id pub-id-type="pmid">21688389</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Droste</surname><given-names>DW</given-names></name><name><surname>Iliescu</surname><given-names>C</given-names></name><name><surname>Vaillant</surname><given-names>M</given-names></name><name><surname>Gantenbein</surname><given-names>M</given-names></name><name><surname>De Bremaeker</surname><given-names>N</given-names></name><name><surname>Lieunard</surname><given-names>C</given-names></name><name><surname>Velez</surname><given-names>T</given-names></name><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Guth</surname><given-names>T</given-names></name><name><surname>Kuemmerle</surname><given-names>A</given-names></name><name><surname>Chioti</surname><given-names>A</given-names></name></person-group><article-title>Lifestyle counseling in patients with carotid arteriosclerosis from Luxemburg should focus more on the reduction of sugar, sodium and saturated fat consumption</article-title><source>Bull Soc Sci Med Grand Duche Luxemb</source><year>2013</year><volume>1</volume><fpage>28</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">23808108</pub-id></element-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Minist&#x000e8;re de la</surname><given-names>Sant&#x000e9;</given-names></name></person-group><source>Alimentation Saine et Activit&#x000e9; Physique</source>. <ext-link ext-link-type="uri" xlink:href="http://www.sante.public.lu/publications/rester-bonne-sante/alimentation/plan-national-alimentation-saine-activite-physique/plan-national-alimentation-saine-activite-physique.pdf">http://www.sante.public.lu/publications/rester-bonne-sante/alimentation/plan-national-alimentation-saine-activite-physique/plan-national-alimentation-saine-activite-physique.pdf</ext-link>, Luxembourg, 2007.</mixed-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mente</surname><given-names>A</given-names></name><name><surname>de Koning</surname><given-names>L</given-names></name><name><surname>Shannon</surname><given-names>HS</given-names></name><name><surname>Anand</surname><given-names>SS</given-names></name></person-group><article-title>A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease</article-title><source>Arch Intern Med</source><year>2009</year><volume>169</volume><fpage>659</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">19364995</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damasceno</surname><given-names>NR</given-names></name><name><surname>Perez-Heras</surname><given-names>A</given-names></name><name><surname>Serra</surname><given-names>M</given-names></name><name><surname>Cofan</surname><given-names>M</given-names></name><name><surname>Sala-Vila</surname><given-names>A</given-names></name><name><surname>Salas-Salvado</surname><given-names>J</given-names></name><name><surname>Ros</surname><given-names>E</given-names></name></person-group><article-title>Crossover study of diets enriched with virgin olive oil, walnuts or almonds. Effects on lipids and other cardiovascular risk markers</article-title><source>Nutr Metab Cardiovasc Dis</source><year>2011</year><volume>21</volume><issue>suppl 1</issue><fpage>S14</fpage><lpage>S20</lpage><pub-id pub-id-type="pmid">21421296</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mursu</surname><given-names>J</given-names></name><name><surname>Voutilainen</surname><given-names>S</given-names></name><name><surname>Nurmi</surname><given-names>T</given-names></name><name><surname>Rissanen</surname><given-names>TH</given-names></name><name><surname>Virtanen</surname><given-names>JK</given-names></name><name><surname>Kaikkonen</surname><given-names>J</given-names></name><name><surname>Nyyssonen</surname><given-names>K</given-names></name><name><surname>Salonen</surname><given-names>JT</given-names></name></person-group><article-title>Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans</article-title><source>Free Radic Biol Med</source><year>2004</year><volume>37</volume><fpage>1351</fpage><lpage>1359</lpage><pub-id pub-id-type="pmid">15454274</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elkind</surname><given-names>MS</given-names></name><name><surname>Sciacca</surname><given-names>R</given-names></name><name><surname>Boden-Albala</surname><given-names>B</given-names></name><name><surname>Rundek</surname><given-names>T</given-names></name><name><surname>Paik</surname><given-names>MC</given-names></name><name><surname>Sacco</surname><given-names>RL</given-names></name></person-group><article-title>Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study</article-title><source>Stroke</source><year>2006</year><volume>37</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">16306464</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkins</surname><given-names>K</given-names></name></person-group><article-title>Moderate alcohol consumption and heart disease</article-title><source>Health Rep</source><year>2002</year><volume>14</volume><fpage>9</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">15069799</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>E</given-names></name><name><surname>Asmar</surname><given-names>R</given-names></name><name><surname>Beilin</surname><given-names>L</given-names></name><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Mallion</surname><given-names>JM</given-names></name><name><surname>Mancia</surname><given-names>G</given-names></name><name><surname>Mengden</surname><given-names>T</given-names></name><name><surname>Myers</surname><given-names>M</given-names></name><name><surname>Padfield</surname><given-names>P</given-names></name><name><surname>Palatini</surname><given-names>P</given-names></name><name><surname>Parati</surname><given-names>G</given-names></name><name><surname>Pickering</surname><given-names>T</given-names></name><name><surname>Redon</surname><given-names>J</given-names></name><name><surname>Staessen</surname><given-names>J</given-names></name><name><surname>Stergiou</surname><given-names>G</given-names></name><name><surname>Verdecchia</surname><given-names>P</given-names></name></person-group><article-title>European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement</article-title><source>J Hypertens</source><year>2003</year><volume>21</volume><fpage>821</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">12714851</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parati</surname><given-names>G</given-names></name><name><surname>Stergiou</surname><given-names>GS</given-names></name><name><surname>Asmar</surname><given-names>R</given-names></name><name><surname>Bilo</surname><given-names>G</given-names></name><name><surname>de</surname><given-names>LP</given-names></name><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Kario</surname><given-names>K</given-names></name><name><surname>Lurbe</surname><given-names>E</given-names></name><name><surname>Manolis</surname><given-names>A</given-names></name><name><surname>Mengden</surname><given-names>T</given-names></name><name><surname>O'Brien</surname><given-names>E</given-names></name><name><surname>Ohkubo</surname><given-names>T</given-names></name><name><surname>Padfield</surname><given-names>P</given-names></name><name><surname>Palatini</surname><given-names>P</given-names></name><name><surname>Pickering</surname><given-names>TG</given-names></name><name><surname>Redon</surname><given-names>J</given-names></name><name><surname>Revera</surname><given-names>M</given-names></name><name><surname>Ruilope</surname><given-names>LM</given-names></name><name><surname>Shennan</surname><given-names>A</given-names></name><name><surname>Staessen</surname><given-names>JA</given-names></name><name><surname>Tisler</surname><given-names>A</given-names></name><name><surname>Waeber</surname><given-names>B</given-names></name><name><surname>Zanchetti</surname><given-names>A</given-names></name><name><surname>Mancia</surname><given-names>G</given-names></name></person-group><article-title>European Society of Hypertension practice guidelines for home blood pressure monitoring</article-title><source>J Hum Hypertens</source><year>2010</year><volume>24</volume><fpage>779</fpage><lpage>785</lpage><pub-id pub-id-type="pmid">20520631</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>VJ</given-names></name><name><surname>Obarzanek</surname><given-names>E</given-names></name><name><surname>Cook</surname><given-names>NR</given-names></name><name><surname>Lee</surname><given-names>IM</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Smith</surname><given-names>WD</given-names></name><name><surname>Milas</surname><given-names>NC</given-names></name><name><surname>Mattfeldt-Beman</surname><given-names>M</given-names></name><name><surname>Belden</surname><given-names>L</given-names></name><name><surname>Bragg</surname><given-names>C</given-names></name><name><surname>Millstone</surname><given-names>M</given-names></name><name><surname>Raczynski</surname><given-names>J</given-names></name><name><surname>Brewer</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>B</given-names></name><name><surname>Cohen</surname><given-names>J</given-names></name></person-group><article-title>Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II</article-title><source>Ann Intern Med</source><year>2001</year><volume>134</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">11187414</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamsson</surname><given-names>V</given-names></name><name><surname>Reumark</surname><given-names>A</given-names></name><name><surname>Fredriksson</surname><given-names>IB</given-names></name><name><surname>Hammarstrom</surname><given-names>E</given-names></name><name><surname>Vessby</surname><given-names>B</given-names></name><name><surname>Johansson</surname><given-names>G</given-names></name><name><surname>Riserus</surname><given-names>U</given-names></name></person-group><article-title>Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: a randomized controlled trial (NORDIET)</article-title><source>J Intern Med</source><year>2011</year><volume>269</volume><fpage>150</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">20964740</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Moore</surname><given-names>TJ</given-names></name><name><surname>Obarzanek</surname><given-names>E</given-names></name><name><surname>Vollmer</surname><given-names>WM</given-names></name><name><surname>Svetkey</surname><given-names>LP</given-names></name><name><surname>Sacks</surname><given-names>FM</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Vogt</surname><given-names>TM</given-names></name><name><surname>Cutler</surname><given-names>JA</given-names></name><name><surname>Windhauser</surname><given-names>MM</given-names></name><name><surname>Lin</surname><given-names>PH</given-names></name><name><surname>Karanja</surname><given-names>N</given-names></name></person-group><article-title>A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group</article-title><source>N Engl J Med</source><year>1997</year><volume>336</volume><fpage>1117</fpage><lpage>1124</lpage><pub-id pub-id-type="pmid">9099655</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>KJ</given-names></name><name><surname>Bacher</surname><given-names>AC</given-names></name><name><surname>Turner</surname><given-names>KL</given-names></name><name><surname>Fleg</surname><given-names>JL</given-names></name><name><surname>Hees</surname><given-names>PS</given-names></name><name><surname>Shapiro</surname><given-names>EP</given-names></name><name><surname>Tayback</surname><given-names>M</given-names></name><name><surname>Ouyang</surname><given-names>P</given-names></name></person-group><article-title>Effect of exercise on blood pressure in older persons: a randomized controlled trial</article-title><source>Arch Intern Med</source><year>2005</year><volume>165</volume><fpage>756</fpage><lpage>762</lpage><pub-id pub-id-type="pmid">15824294</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>H</given-names></name><name><surname>Kawano</surname><given-names>Y</given-names></name><name><surname>Kojima</surname><given-names>S</given-names></name><name><surname>Ashida</surname><given-names>T</given-names></name><name><surname>Kuramochi</surname><given-names>M</given-names></name><name><surname>Matsuoka</surname><given-names>H</given-names></name><name><surname>Omae</surname><given-names>T</given-names></name></person-group><article-title>Biphasic effects of repeated alcohol intake on 24-hour blood pressure in hypertensive patients</article-title><source>Circulation</source><year>1994</year><volume>89</volume><fpage>2626</fpage><lpage>2633</lpage><pub-id pub-id-type="pmid">8205674</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosito</surname><given-names>GA</given-names></name><name><surname>Fuchs</surname><given-names>FD</given-names></name><name><surname>Duncan</surname><given-names>BB</given-names></name></person-group><article-title>Dose-dependent biphasic effect of ethanol on 24-h blood pressure in normotensive subjects</article-title><source>Am J Hypertens</source><year>1999</year><volume>12</volume><fpage>236</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">10090355</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bau</surname><given-names>PF</given-names></name><name><surname>Bau</surname><given-names>CH</given-names></name><name><surname>Naujorks</surname><given-names>AA</given-names></name><name><surname>Rosito</surname><given-names>GA</given-names></name></person-group><article-title>Early and late effects of alcohol ingestion on blood pressure and endothelial function</article-title><source>Alcohol</source><year>2005</year><volume>37</volume><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">16472719</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilera</surname><given-names>MT</given-names></name><name><surname>de la Sierra</surname><given-names>A</given-names></name><name><surname>Coca</surname><given-names>A</given-names></name><name><surname>Estruch</surname><given-names>R</given-names></name><name><surname>Fernandez-Sola</surname><given-names>J</given-names></name><name><surname>Urbano-Marquez</surname><given-names>A</given-names></name></person-group><article-title>Effect of alcohol abstinence on blood pressure: assessment by 24-hour ambulatory blood pressure monitoring</article-title><source>Hypertension</source><year>1999</year><volume>33</volume><fpage>653</fpage><lpage>657</lpage><pub-id pub-id-type="pmid">10024322</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zilkens</surname><given-names>RR</given-names></name><name><surname>Burke</surname><given-names>V</given-names></name><name><surname>Hodgson</surname><given-names>JM</given-names></name><name><surname>Barden</surname><given-names>A</given-names></name><name><surname>Beilin</surname><given-names>LJ</given-names></name><name><surname>Puddey</surname><given-names>IB</given-names></name></person-group><article-title>Red wine and beer elevate blood pressure in normotensive men</article-title><source>Hypertension</source><year>2005</year><volume>45</volume><fpage>874</fpage><lpage>879</lpage><pub-id pub-id-type="pmid">15837829</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatami</surname><given-names>S</given-names></name><name><surname>Sarashina</surname><given-names>A</given-names></name><name><surname>Yamamura</surname><given-names>N</given-names></name><name><surname>Igarashi</surname><given-names>T</given-names></name><name><surname>Tanigawara</surname><given-names>Y</given-names></name></person-group><article-title>Population pharmacokinetics of an angiotensin II receptor antagonist, telmisartan, in healthy volunteers and hypertensive patients</article-title><source>Drug Metab Pharmacokinet</source><year>2003</year><volume>18</volume><fpage>203</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">15618736</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Baseline demographic values, past medical history, BP treatment and mean BP and HR</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">No LC</th><th align="left" rowspan="1" colspan="1">LC</th><th align="left" rowspan="1" colspan="1">p value</th><th align="left" rowspan="1" colspan="1">Red wine</th><th align="left" rowspan="1" colspan="1">No red wine</th><th align="left" rowspan="1" colspan="1">p value</th><th align="left" rowspan="1" colspan="1">Total</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">53</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">52</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">108</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean age, years</td><td align="left" rowspan="1" colspan="1">63.4 (10.6)</td><td align="left" rowspan="1" colspan="1">63.7 (8.1)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">64.1 (9.1)</td><td align="left" rowspan="1" colspan="1">63.0 (9.9)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">63.6 (9.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Men, %</td><td align="left" rowspan="1" colspan="1">69</td><td align="left" rowspan="1" colspan="1">64</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">68</td><td align="left" rowspan="1" colspan="1">65</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">67</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily alcohol intake, g</td><td align="left" rowspan="1" colspan="1">14.7 (14.7)</td><td align="left" rowspan="1" colspan="1">14.5 (14.2)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">15.4 (14.3)</td><td align="left" rowspan="1" colspan="1">13.7 (14.6)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">14.6 (14.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily alcohol intake of men, g</td><td align="left" rowspan="1" colspan="1">16.2 (14.5)</td><td align="left" rowspan="1" colspan="1">15.2 (11.9)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">16.5 (13.4)</td><td align="left" rowspan="1" colspan="1">14.8 (13.2)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">15.7 (13.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily alcohol intake of women, g</td><td align="left" rowspan="1" colspan="1">11.4 (14.9)</td><td align="left" rowspan="1" colspan="1">13.4 (18.0)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">13.0 (16.0)</td><td align="left" rowspan="1" colspan="1">11.8 (17.2)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">12.4 (16.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean weight, kg</td><td align="left" rowspan="1" colspan="1">81.6 (16.2)</td><td align="left" rowspan="1" colspan="1">77.2 (16.3)</td><td align="left" rowspan="1" colspan="1">n. s.</td><td align="left" rowspan="1" colspan="1">79.5 (14.3)</td><td align="left" rowspan="1" colspan="1">79.4 (18.4)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">79.4 (16.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean BMI</td><td align="left" rowspan="1" colspan="1">27.8 (4.2)</td><td align="left" rowspan="1" colspan="1">27.3 (4.5)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">27.4 (3.9)</td><td align="left" rowspan="1" colspan="1">27.7 (4.8)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">27.6 (4.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Smokers, %</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension, %</td><td align="left" rowspan="1" colspan="1">69</td><td align="left" rowspan="1" colspan="1">66</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">68</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyper-/dyslipidemia, %</td><td align="left" rowspan="1" colspan="1">76</td><td align="left" rowspan="1" colspan="1">72</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">77</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">74</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus, %</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous stroke, %</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous TIA, %</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous MI, %</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">9</td></tr><tr><td align="left" rowspan="1" colspan="1">Angina pectoris, %</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">Intermittent claudication, %</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">On ACE inhibitor, %</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">On angiotensin II antagonist, %</td><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">44</td></tr><tr><td align="left" rowspan="1" colspan="1">On calcium antagonist, %</td><td align="left" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">27</td></tr><tr><td align="left" rowspan="1" colspan="1">On beta blocker, %</td><td align="left" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">33</td></tr><tr><td align="left" rowspan="1" colspan="1">On diuretic, %</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1">On renin inhibitor, %</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">On alpha blocker, %</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">not tested</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean 24-hour systolic BP, mm Hg</td><td align="left" rowspan="1" colspan="1">121.6 (10.9)</td><td align="left" rowspan="1" colspan="1">122.8 (11.6)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">122.7 (12.4)</td><td align="left" rowspan="1" colspan="1">121.6 (9.8)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">122.2 (11.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean 24-hour diastolic BP, mm Hg</td><td align="left" rowspan="1" colspan="1">79.4 (8.1)</td><td align="left" rowspan="1" colspan="1">78.0 (7.9)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">79.3 (8.6)</td><td align="left" rowspan="1" colspan="1">78.1 (7.3)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">78.7 (8.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean 24-hour HR, bpm</td><td align="left" rowspan="1" colspan="1">71.4 (7.3)</td><td align="left" rowspan="1" colspan="1">70.5 (7.7)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">70.8 (7.1.)</td><td align="left" rowspan="1" colspan="1">71.1 (8.0)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">70.9 (7.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean diurnal SBP, mm Hg</td><td align="left" rowspan="1" colspan="1">124.2 (10.5)</td><td align="left" rowspan="1" colspan="1">126.1 (12.0)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">126.1 (12.5)</td><td align="left" rowspan="1" colspan="1">124.1 (9.7)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">125.1 (11.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean diurnal DBP, mm Hg</td><td align="left" rowspan="1" colspan="1">83.4 (8.9)</td><td align="left" rowspan="1" colspan="1">82.3 (8.6)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">83.8 (9.4)</td><td align="left" rowspan="1" colspan="1">81.8 (7.8)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">82.9 (8.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean diurnal HR, bpm</td><td align="left" rowspan="1" colspan="1">74.8 (7.8)</td><td align="left" rowspan="1" colspan="1">73.5 (8.2)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">73.9 (7.5)</td><td align="left" rowspan="1" colspan="1">74.5 (8.5)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">74.2 (8.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean nocturnal SBP, mm Hg</td><td align="left" rowspan="1" colspan="1">115.9 (14.3)</td><td align="left" rowspan="1" colspan="1">114.9 (14.2)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">115.1 (15.6)</td><td align="left" rowspan="1" colspan="1">115.7 (12.6)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">115.4 (14.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean nocturnal DBP, mm Hg</td><td align="left" rowspan="1" colspan="1">70.4 (8.6)</td><td align="left" rowspan="1" colspan="1">68.2 (9.0)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">69.4 (9.3)</td><td align="left" rowspan="1" colspan="1">69.2 (8.4)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">69.3 (8.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean nocturnal HR, bpm</td><td align="left" rowspan="1" colspan="1">63.7 (8.2)</td><td align="left" rowspan="1" colspan="1">63.2 (7.7)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">63.6 (8.0)</td><td align="left" rowspan="1" colspan="1">63.3 (8.0)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">63.5 (7.9)</td></tr></tbody></table><table-wrap-foot><fn><p>Values in parentheses are SD. No differences were found between the LC and the no LC group and between the red wine and the no red wine group in the Student t tests and Wilcoxon-Mann-Whitney tests (indicated by *), respectively. Categorical values were tested with the &#x003c7;<sup>2</sup> test or Fisher's exact test, respectively. TIA = Transient ischemic attack; MI = myocardial infarction; ACE = angiotensin-converting enzyme.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Distribution of BP values at baseline for the whole cohort of 108 patients</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Low</th><th align="left" rowspan="1" colspan="1">Normal</th><th align="left" rowspan="1" colspan="1">Borderline</th><th align="left" rowspan="1" colspan="1">Mild</th><th align="left" rowspan="1" colspan="1">Moderate</th><th align="left" rowspan="1" colspan="1">Severe</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Diurnal SBP</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">91 (84.26)</td><td align="left" rowspan="1" colspan="1">8 (7.41)</td><td align="left" rowspan="1" colspan="1">7 (6.48)</td><td align="left" rowspan="1" colspan="1">2 (1.85)</td><td align="left" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Diurnal DBP</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">72 (66.67)</td><td align="left" rowspan="1" colspan="1">16 (14.81)</td><td align="left" rowspan="1" colspan="1">16 (14.81)</td><td align="left" rowspan="1" colspan="1">4 (3.70)</td><td align="left" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Nocturnal SBP</td><td align="left" rowspan="1" colspan="1">1 (0.93)</td><td align="left" rowspan="1" colspan="1">74 (68.52)</td><td align="left" rowspan="1" colspan="1">12 (11.11)</td><td align="left" rowspan="1" colspan="1">11 (10.19)</td><td align="left" rowspan="1" colspan="1">8 (7.41)</td><td align="left" rowspan="1" colspan="1">2 (1.85)</td></tr><tr><td align="left" rowspan="1" colspan="1">Nocturnal DBP</td><td align="left" rowspan="1" colspan="1">1 (0.93)</td><td align="left" rowspan="1" colspan="1">64 (59.26)</td><td align="left" rowspan="1" colspan="1">17 (15.74)</td><td align="left" rowspan="1" colspan="1">21 (19.44)</td><td align="left" rowspan="1" colspan="1">4 (3.70)</td><td align="left" rowspan="1" colspan="1">1 (0.93)</td></tr></tbody></table><table-wrap-foot><fn><p>Values are numbers of subjects with percentages in parentheses. The vast majority of the subjects was normotensive. To classify BP, we used the limits of the European Society of Hypertension. For orientation, normal diurnal SBP was 100-135 mm Hg, nocturnal SBP 91&#x02013;120 mm Hg, diurnal DBP 65&#x02013;85 mm Hg and nocturnal DBP 51&#x02013;70 mm Hg [<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B33">33</xref>].</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Absolute change of BP and HR</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">No LC (n = 55)</th><th align="left" rowspan="1" colspan="1">LC (n = 53)</th><th align="left" rowspan="1" colspan="1">P</th><th align="left" rowspan="1" colspan="1">Red wine (n = 56)</th><th align="left" rowspan="1" colspan="1">No red wine (n = 52)</th><th align="left" rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>Baseline &#x02013; 4 weeks</italic></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean 24-hour SBP, mm Hg</td><td align="left" rowspan="1" colspan="1">&#x02013;0.9 (9.3)</td><td align="left" rowspan="1" colspan="1">&#x02013;1.3 (8.6)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">&#x02013;1.6 (9.6)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.5 (8.0)</td><td align="left" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean 24-hour DBP, mm Hg</td><td align="left" rowspan="1" colspan="1">&#x02013;0.0 (5.9)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.8 (5.6)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">&#x02013;0.9 (6.0)</td><td align="left" rowspan="1" colspan="1">0.2 (5.4)</td><td align="left" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean 24-hour HR, bpm</td><td align="left" rowspan="1" colspan="1">&#x02013;0.6 (4.7)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.4 (6.1)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">0.1 (5.5)</td><td align="left" rowspan="1" colspan="1">&#x02013;1.1 (5.3)</td><td align="left" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean diurnal SBP, mm Hg</td><td align="left" rowspan="1" colspan="1">&#x02013;0.5 (9.3)</td><td align="left" rowspan="1" colspan="1">&#x02013;1.9 (9.3)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">&#x02013;1.7 (10.0)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.6 (8.5)</td><td align="left" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean diurnal DBP, mm Hg</td><td align="left" rowspan="1" colspan="1">0.3 (6.2)</td><td align="left" rowspan="1" colspan="1">&#x02013;1.1 (6.5)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">&#x02013;1.0 (6.4)</td><td align="left" rowspan="1" colspan="1">0.3 (6.3)</td><td align="left" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean diurnal HR, bpm</td><td align="left" rowspan="1" colspan="1">&#x02013;0.9 (5.3)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.1 (6.4)</td><td align="left" rowspan="1" colspan="1">n.s*</td><td align="left" rowspan="1" colspan="1">0.1 (5.9)</td><td align="left" rowspan="1" colspan="1">&#x02013;1.1 (5.9)</td><td align="left" rowspan="1" colspan="1">n.s.*</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean nocturnal SBP, mm Hg</td><td align="left" rowspan="1" colspan="1">&#x02013;2.1 (11.0)</td><td align="left" rowspan="1" colspan="1">0.6 (11.6)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">&#x02013;1.4 (11.7)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.2 (11.0)</td><td align="left" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean nocturnal DBP, mm Hg</td><td align="left" rowspan="1" colspan="1">&#x02013;1.2 (7.5)</td><td align="left" rowspan="1" colspan="1">0.1 (7.8)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">&#x02013;1.3 (7.8)</td><td align="left" rowspan="1" colspan="1">0.2 (7.4)</td><td align="left" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean nocturnal HR, bpm</td><td align="left" rowspan="1" colspan="1">&#x02013;0.4 (5.2)</td><td align="left" rowspan="1" colspan="1">&#x02013;1.1 (6.7)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">0.0 (6.4)</td><td align="left" rowspan="1" colspan="1">&#x02013;1.5(5.3)</td><td align="left" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Baseline &#x02013; 20 weeks</italic></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean 24-hour SBP, mm Hg</td><td align="left" rowspan="1" colspan="1">&#x02013;0.3 (9.4)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.5 (10.5)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">&#x02013;0.5 (10.1)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.3 (9.7)</td><td align="left" rowspan="1" colspan="1">n.s.*</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean 24-hour DBP, mm Hg</td><td align="left" rowspan="1" colspan="1">&#x02013;0.1 (6.3)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.3 (6.8)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">&#x02013;0.7 (6.5)</td><td align="left" rowspan="1" colspan="1">0.3 (6.6)</td><td align="left" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean 24-hour HR, bpm</td><td align="left" rowspan="1" colspan="1">1.2 (5.6)</td><td align="left" rowspan="1" colspan="1">0.2 (5.0)</td><td align="left" rowspan="1" colspan="1">n.s.*</td><td align="left" rowspan="1" colspan="1">0.9 (5.6)</td><td align="left" rowspan="1" colspan="1">0.4 (5.0)</td><td align="left" rowspan="1" colspan="1">n.s.*</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean diurnal SBP, mm Hg</td><td align="left" rowspan="1" colspan="1">&#x02013;0.8 (9.3)</td><td align="left" rowspan="1" colspan="1">&#x02013;1.4 (11.4)</td><td align="left" rowspan="1" colspan="1">n.s*</td><td align="left" rowspan="1" colspan="1">&#x02013;1.6 (10.6)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.5 (10.2)</td><td align="left" rowspan="1" colspan="1">n.s.*</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean diurnal DBP, mm Hg</td><td align="left" rowspan="1" colspan="1">&#x02013;0.3 (6.8)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.5 (8.4)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">&#x02013;1.4 (7-6)</td><td align="left" rowspan="1" colspan="1">0.7 (7.5)</td><td align="left" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean diurnal HR, bpm</td><td align="left" rowspan="1" colspan="1">0.9 (5.1)</td><td align="left" rowspan="1" colspan="1">0.1 (5.7)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">0.4 (5.3)</td><td align="left" rowspan="1" colspan="1">0.7 (5.5)</td><td align="left" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean nocturnal SBP, mm Hg</td><td align="left" rowspan="1" colspan="1">0.3 (12.4)</td><td align="left" rowspan="1" colspan="1">1.5 (11.7)</td><td align="left" rowspan="1" colspan="1">n.s*</td><td align="left" rowspan="1" colspan="1">1.7 (11.9)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.0 (12.2)</td><td align="left" rowspan="1" colspan="1">n.s.*</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean nocturnal DBP, mm Hg</td><td align="left" rowspan="1" colspan="1">&#x02013;0.0 (7.7)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.1 (7.4)</td><td align="left" rowspan="1" colspan="1">n.s*</td><td align="left" rowspan="1" colspan="1">0.4 (7.2)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.6 (7.9)</td><td align="left" rowspan="1" colspan="1">n.s.*</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean nocturnal HR, bpm</td><td align="left" rowspan="1" colspan="1">0.3 (6.4)</td><td align="left" rowspan="1" colspan="1">0.4 (6.2)</td><td align="left" rowspan="1" colspan="1">n.s.</td><td align="left" rowspan="1" colspan="1">0.8 (6.1)</td><td align="left" rowspan="1" colspan="1">&#x02013;0.2 (6.5)</td><td align="left" rowspan="1" colspan="1">n.s.</td></tr></tbody></table><table-wrap-foot><fn><p>Values in parentheses are SD. p values are from a general linear model. When the values were not normally distributed, ANOVA on ranks was used (indicated by *).</p></fn></table-wrap-foot></table-wrap></floats-group></article>